Skip to main content
Industry News
FDA to regulate insulin as biological product
3/25/2020

The FDA this week changed how it regulates insulin and other biologics, such as human growth hormone and chorionic gonadotropin, to treat them as biological products rather than drugs. The move means any insulin approved as a so-called "follow-on" is now considered a biosimilar and interchangeable with branded products, which could reduce costs.

Full Story: